Arbutus Biopharma Corporation
ABUSUpdated . Prices are snapshots and may be delayed.
Arbutus Biopharma Corporation price chart
AI Outlook for Arbutus Biopharma Corporation
Bearish posture- Long-term trend-6.6% vs 200-day average
- Medium-term trend-12.2% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Arbutus Biopharma Corporation performance
About Arbutus Biopharma Corporation
Arbutus Biopharma Corporation is a biotechnology company based in Canada, listed on NASDAQ since 2010 (ticker ABUS).
The shares trade at a price-to-earnings ratio of 5.8.
Arbutus Biopharma Corporation market data
What is the price of Arbutus Biopharma Corporation today?
Arbutus Biopharma Corporation (ABUS) is at $4.22, −1.63% on the day.
What is the 52-week range of Arbutus Biopharma Corporation?
Over the past year Arbutus Biopharma Corporation has traded between $3.50 and $5.45. It is currently 37% of the way up that range.
What is the P/E ratio of Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation trades at a price-to-earnings ratio of 5.8.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.